Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors

Tuberculosis (TB) remains one of the leading causes of mortality worldwide. Hence, the identification of highly effective antitubercular drugs with novel modes of action is crucial. In this paper, we report the discovery and development of pyrrolo[1,5-a]pyrazine-based analogues as highly potent inhi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ACS Infect Dis
Päätekijät: Garzan, Atefeh, Willby, Melisa J., Ngo, Huy X., Gajadeera, Chathurada S., Green, Keith D., Holbrook, Selina Y. L., Hou, Caixia, Posey, James E., Tsodikov, Oleg V., Garneau-Tsodikova, Sylvie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971065/
https://ncbi.nlm.nih.gov/pubmed/28192916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.6b00193
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia